Live feed
Filing
SC 13D/A
SC 13D/A0001213900-24-106465·Akari Therapeutics Plc
Schedule 13D ownership disclosure
AKARI THERAPEUTICS PLC
Security class unavailable · CUSIP: 00972G207
Event date: 2024-11-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.8500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-24-106465
- Form type
- SC 13D/A
- Filer
- Akari Therapeutics Plc
- CIK
- CIK 1541157
- Filed
- Dec 06, 2024
- Reporting period
- Nov 14, 2024
- Description
- Schedule 13D beneficial ownership